Pyrazole derivatives as malt1 inhibitors

Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows:wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.

Saved in:
Bibliographic Details
Main Authors PHILIPPAR, ULRIKE, CUMMINGS, MAXWELL DAVID, WU, TONGFEI, DIELS, GASTON, EDWARDS, JAMES PATRICK, CONNOLLY, PETER J, LU, TIANBAO, SHEN, FANG, THURING, JOHANNES WILHELMUS JOHN FITZGE, ALLISON, BRETT DOUGLAS, KREUTTER, KEVIN D, BARBAY, JOSEPH KENT
Format Patent
LanguageChinese
English
Published 11.03.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed are compounds, compositions and methods for treating of diseases, syndromes, conditions, and disorders that are affected by the modulation of MALT1. Such compounds are represented by Formula (I) as follows:wherein R1, R2, R3, R4, R5, R6, R5, G1, and G2 are defined herein.
Bibliography:Application Number: TW20176144535